1. Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma
   Hsiang-chi Tseng et al, 2020, Nature Communications CrossRef
2. Autoimmune diseases in China
   Ru Li et al, 2019, Advances in Immunology in China - Part A CrossRef
3. Safety, Biodistribution, and Dosimetry Study of Meplazumab, a Potential COVID-19 Therapeutic Drug, with 131I-Labeling and SPECT Imaging
   Jiajun Ye et al, 2023, Molecular Pharmaceutics CrossRef